Transcranial Direct Current Stimulation: Clinical Trials

115 trials of Transcranial Direct Current Stimulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 completed, 34 unknown, 5 recruiting, 4 terminated. 115 Phase 2, 27 Phase 3, 26 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2115Completed 66, Unknown 34, Recruiting 5, Terminated 4, Active not recruiting 2, Not yet recruiting 2, Suspended 1, Withdrawn 1
Phase 327Completed 18, Unknown 8, Recruiting 1
Phase 126Completed 17, Unknown 5, Terminated 2, Not yet recruiting 1, Recruiting 1

Follow Transcranial Direct Current Stimulation: new trials by email Literature Review of Transcranial Direct Current Stimulation trials Research Report on Transcranial Direct Current Stimulation

Trials (filtered) newest first · largest first

All 115 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Remotely Administered tDCS to Improve Cognitive Function in Veterans With mTBI and PTSD Principal Investigator
Transcranial direct current stimulation (tDCS), Cognitive training - Cognition, Brain Injuries
Phase 2Not yet recruitingVA Office of Research and Development462027-05-242026-02-17
tDCS for Late-Life Depression
High-intensity (6 mA) transcranial direct current stimulation (tDCS) - Late Life Depression (LLD), Depression - Major Depressive Disorder
Phase 1 / Phase 2RecruitingAndre Russowsky Brunoni202026-10-012026-09-25
Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation
Transcranial alternating current stimulation (tACS), Sham treatment - Stroke, Cerebrovascular Accident (CVA)
Phase 1 / Phase 2Not yet recruitingVrije Universiteit Brussel1202026-09-012026-05-29
Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation
tDCS - Aphasia, Broca's Aphasia
Phase 2 / Phase 3RecruitingUniversity of South Carolina1302026-07-142026-07-21
Synergistic Effect of Non-invasive Brain and Spinal Cord Stimulation
tDCS, tSCS, Sham - Stroke, Spinal Cord Injury
Phase 2RecruitingCentre National de la Recherche Scientifique, France452024-12-112026-01-12
tDCS for Post-Stroke Cognitive Impairment
Transcranial Dirrect Current Stimulation - Stroke, Mild Cognitive Impairment
Phase 2RecruitingUniversity of Oklahoma802024-09-302024-10-10
Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders
tDCS or Transcranial Direct Current Stimulation, Risperidone, Sham tDCS - Attention, Visual Perceptual Weakness
Phase 1 / Phase 2CompletedSpanish Foundation for Neurometrics Development1802024-04-012026-09-10
Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA
BDJ, tDCS, sham tDCS - Knee Osteoarthritis
Phase 2RecruitingMassachusetts General Hospital1402024-03-052026-07-17
tDCS in the Management of Post-COVID Disorders
Transcranial Direct Current Stimulation (tDCS), Motor Training, Cognitive Training - Long COVID
Phase 2UnknownUniversidade Federal de Pernambuco482023-08-252024-04-24
Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)
Transcranial Direct Current Stimulation (tDCS), Word-Naming Activity - Primary Progressive Aphasia
Phase 2CompletedNYU Langone Health112022-12-242024-09-19
A Teleheath tDCS Approach to Decrease Cannabis Use
Transcranial Direct Current Stimulation (tDCS), Sham - Transcranial Direct Current Stimulation (tDCS), Mindfulness - Cannabis Use Disorder, Multiple Sclerosis
Phase 2CompletedNYU Langone Health522022-09-132025-06-24
TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic
Transcranial Direct Current Stimulation, Placebo-simulation of transcranial direct current stimulation, Fluoxetine Tablets - Major Depressive Disorder
Phase 2 / Phase 3UnknownEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez1722021-10-012021-06-04
Neuromodulation in COVID-19 Patients
Transcranial direct-current stimulation, Sham Transcranial direct-current stimulation - COVID-19
Phase 1 / Phase 2CompletedD'Or Institute for Research and Education602021-08-102021-10-14
Apply tACS to Alleviate Anxiety Symptoms
transcranial alternating current stimulation (tACS) - Anxiety Disorders
Phase 2UnknownNeuroCognitive and Behavioral Institute Clinical Research Foundation402021-06-012023-10-18
Transcranial Direct Current Stimulation to Reduce Chronic Pelvic Pain in Endometriosis
tDCS : Transcranial direct current stimulation - Endometriosis
Phase 2UnknownCharite University, Berlin, Germany402021-01-012022-02-09
Effects of tDCS on Anaerobic Power of Lower Limb Muscles
Transcranial direct current stimulation - Healthy Volunteers
Phase 2 / Phase 3CompletedUniversidade Federal do Piauí502021-01-012021-05-03
Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome
Omega-3 polyunsaturated fatty acids, Xbox aerobic exercise, transcranial direct current stimulation,tDCS - Schizophrenia
Phase 2SuspendedShanghai Mental Health Center1202020-10-012023-04-18
Biomarkers of Response to Treatment With Frontal Cortex Stimulation for Anxious Depression
transcranial direct current stimulation using a Soterix mini-CT device - Major Depressive Disorder, Anxiety
Phase 1 / Phase 2TerminatedMclean Hospital12020-02-132021-02-12
DAOIB Combined With tDCS for Early-phase Dementia
DAOIB, Placebo, tDCS - Transcranial Direct Current Stimulation, Dementia
Phase 2CompletedChang Gung Memorial Hospital972020-01-012023-01-06
Imaging the Effects of Bihemispheric Transcranial Stimulation and Motor Training After Stroke.
tDCS + upper limb rehabilitation, Sham tDCS + upper limb rehabilitation - Stroke
Phase 2UnknownD'Or Institute for Research and Education242019-10-292019-12-11

Showing 20 of 115. Sign in to see all of them.

Conditions studied

Stroke (23)  ·  Depressive Disorder, Major (13)  ·  Depression (10)  ·  Cognitive Dysfunction (6)  ·  Pain (6)  ·  Schizophrenia (6)  ·  Fibromyalgia (5)  ·  Aphasia (4)  ·  Bipolar Disorder (4)  ·  Cerebral Infarction (4)  ·  Parkinson Disease (4)  ·  Anxiety Disorders (3)  ·  Cerebrovascular Disorders (3)  ·  Inflammatory Bowel Diseases (3)  ·  Migraine Disorders (3)

Sponsors

The University of New South Wales (8)  ·  Universidade Federal de Pernambuco (7)  ·  University of Sao Paulo (7)  ·  Federal University of Paraíba (6)  ·  Universidade Federal do Piauí (6)  ·  Charite University, Berlin, Germany (4)  ·  Federal University of Espirito Santo (3)  ·  Hospital de Clinicas de Porto Alegre (3)  ·  University of Liege (3)  ·  Centre Hospitalier Universitaire de Besancon (2)  ·  D'Or Institute for Research and Education (2)  ·  El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez (2)  ·  Massachusetts General Hospital (2)  ·  NYU Langone Health (2)  ·  Northwell Health (2)

Countries

Brazil (39)  ·  United States (26)  ·  Australia (8)  ·  Germany (8)  ·  France (6)  ·  Belgium (5)  ·  Canada (4)  ·  South Korea (3)  ·  Italy (2)  ·  Mexico (2)  ·  Austria (1)  ·  China (1)  ·  Serbia (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Andre R Brunoni, MD (3)  ·  Colleen Loo (2)  ·  Erika C Rodrigues, PhD (2)  ·  Ester M Nakamura-Palacios, MD, PhD (2)  ·  Fernanda F Tovar-Moll, PhD (2)  ·  Fuad Hazime, PhD (2)  ·  Leigh Charvet, PhD (2)  ·  Adriana Baltar, PhD (1)  ·  Agnes Floeel, Prof MD (1)  ·  Agnes Floel, MD (1)  ·  Alessandra Lugaresi, MD, PhD (1)  ·  Alexandre DaSilva, DDS, MS (1)

Results publications

PMID 33175411, PMID 21167786, PMID 22215866, PMID 27173384, PMID 10990547, PMID 11063978, PMID 11723286, PMID 12244081, PMID 12949224, PMID 14677403, PMID 15147306, PMID 15351385, PMID 15987799, PMID 16002441, PMID 16499758, PMID 16794566, PMID 17133529, PMID 17591596, PMID 19332318, PMID 19403329, PMID 19671217, PMID 19853048, PMID 20633386, PMID 21068312, PMID 21441148, PMID 21470608, PMID 21631313, PMID 21636820, PMID 21890211, PMID 22032743, PMID 22189047, PMID 22193671, PMID 22341482, PMID 22579647, PMID 23273725, PMID 23370085, PMID 23389323, PMID 23719070, PMID 23759172, PMID 23851401, PMID 23893039, PMID 23920122, PMID 24119615, PMID 24139147, PMID 24262299, PMID 24486425, PMID 25153776, PMID 25309825, PMID 25371383, PMID 25454337

NIH funding

1IK2RD000464-01A2 (1), 2014 (1), K01HD069504 (1), R01AG060981 (1), U01DC022447 (1), U01NS102353 (1)